Are lung nodules common after Bendeka & Rituxan therapy?
- Lung nodules are not commonly found after Bendeka and Rituxan therapy.
- Rarely, interstitial lung disease has been reported with rituximab treatment, and in a couple of cases people were taking bendamustine (Bendeka) as well.
- Lung nodules are commonly found during routine x-rays, showing up on one in every 500 x-rays. Most are benign (noncancerous).
Although there have been a few case reports of interstitial lung disease (ILD) developing following Rituximab (RTX) therapy, it is considered a rare complication of rituximab therapy but one that doctors should monitor for because it may be potentially fatal.
Published case reports mostly reported ILD happening in people taking Rituximab; however, at least two reported the combination of rituximab and bendamustine (Bendeka), for example:
- A 71-year-old man who developed ILD one month after finishing two treatment cycles of RTX and bendamustine with a 2-week interval
- A 63-year-old man who had weekly RTX for 4 weeks, followed by a combination of RTX and bendamustine.
Interstitial Lung Disease (ILD) is an umbrella term for a large group of lung diseases that cause scarring (fibrosis) of the lungs. Scarring makes it difficult to breathe and get oxygen to the bloodstream.
What is a lung nodule?
A lung nodule is a small round or oval solid overgrowth of tissue in the lungs that is seen on an X-ray or computed tomography (CT) scan.
Nodules are common and they show up on about one in every 500 chest x-rays. There may be just one solitary nodule or there may be several. Lung nodules may be benign (noncancerous) or cancerous. Nodules are more likely to be benign if:
- They are small
- There is calcium in the nodule
- You are younger than 40
- You do not smoke.
References
- Bendeka (bendamustine) Teva Pharmaceuticals USA, Inc. https://www.drugs.com/pro/bendeka.html#s-34090-1
- Bendamustine Chemocare. http://chemocare.com/chemotherapy/drug-info/bendamustine.aspx
- Bendeka (bendamustine) Medical News Today. 2020 https://www.medicalnewstoday.com/articles/bendeka;
- Uma Maheswari Krishnaswamy, Vinayak V. Maka, Murali Subramanian, et al. Rituximab Induced Interstitial Lung Disease in Patients with Non-Hodgkin’s Lymphoma: A Clinical Study of Six Cases and Review of the Literature Lymphoma, 2014. https://doi.org/10.1155/2014/160421
Read next
How soon can you start chemo after port placement?
Chemotherapy can typically begin within a few days to 2 weeks after port placement, depending on factors like healing progress and treatment urgency. While same-day chemotherapy is possible in some cases, most healthcare providers recommend a short waiting period to ensure proper recovery and port functionality.
Continue reading
What is the difference between Truxima and Rituxan?
Truxima (rituximab-abbs) is a biosimilar to Rituxan (rituximab). While both drugs are CD20-directed cytolytic antibodies used to treat non-Hodgkin’s lymphoma (NHL), Rituxan has additional FDA-approved indications beyond NHL. Continue reading
What is the success rate of Rituxan (rituximab) in patients with blood cancers?
In patients with hematological or blood cancers, including non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL), Rituxan’s success is measured in a number of ways. It is measured by looking at how long patients responded to treatment (median duration of response), how long they live without their disease progressing (progression-free survival) and how many patients respond to treatment (response rate).
Rituxan treatment improves outcomes in certain patients with NHL. Adding Rituxan alongside standard therapies enhances the response patients have to treatment and improves overall outcomes, including increasing the time patients live for without experiencing a progression of their disease.
Rituxan helps to improve overall survival in certain patients with CLL and also helps to increase the time patients live for without experiencing disease progression. Adding Rituxan alongside standard therapy enhances the response patients have to therapy. Continue reading
See also:
Aimovig
Learn about Aimovig (erenumab-aooe) a once-monthly, injectable medication that can be ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Humira
Humira is a tumor necrosis factor blocker used to treat many inflammatory conditions in adults ...
Nurtec ODT
Nurtec ODT (rimegepant) is used to treat acute migraines and prevent episodic migraines, by ...
Emgality
Emgality (galcanezumab-gnlm) is a CGRP antagonist for the preventive treatment of migraine and for ...
Inderal
Inderal (propranolol) is used to treat angina, high blood pressure and heart rhythm disorders ...
Ajovy
Ajovy (fremanezumab-vfrm) is a preventive migraine treatment. Includes Ajovy side effects ...
Vyepti
Vyepti (eptinezumab-jjmr) is used for the preventive treatment of migraine. Includes Vyepti ...
Botox Cosmetic
Botox Cosmetic is a prescription treatment for fine lines and wrinkles. It temporarily improves the ...
Fremanezumab
Fremanezumab is used for chronic migraine, headache, migraine, migraine prevention
Related medical questions
- What are the new drugs for rheumatoid arthritis (RA)?
- What is the success rate of Rituxan (rituximab) in rheumatoid arthritis?
- What causes infusion reactions to rituximab?
- What is the difference between Rituxan and Rituxan Hycela?
- What are biologic drugs and how do they work?
- What biosimilars have been approved in the United States?
- How will I feel after a Rituxan infusion?
- What are monoclonal antibodies?
- How long does it take for Rituxan to work?
- What are biosimilar drugs and how do they compare to biologics?
- Does Rituxan cause hair loss?
- How does the drug Rituxan work?
- How do you prepare for a Rituxan infusion?
- How is Bendeka different to Treanda?
- Why has Bendeka replaced Treanda?
- How often is Bendeka given and how long does treatment last?
- Does Treanda cause hair loss?
- What is Treanda used for and how does it work?
- What is Bendeka used for?
Drug information
Related support groups
- Rituximab (12 questions, 56 members)
- Rituxan (21 questions, 105 members)
- Bendamustine (7 questions, 13 members)
- Bendeka (5 questions, 3 members)